Results 211 to 220 of about 832,216 (359)

2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Ca

European Heart Journal, 2014
S. Windecker, P. Kolh, F. Alfonso, J. Collet, J. Cremer, V. Falk, G. Filippatos, C. Hamm, S. Head, P. Jüni, A. Kappetein, A. Kastrati, J. Knuuti, U. Landmesser, G. Laufer, F. Neumann, D. Richter, P. Schauerte, M. Sousa Uva, G. Stefanini, D. Taggart, L. Torracca, M. Valgimigli, W. Wijns, A. Witkowski   +24 more
semanticscholar   +1 more source

Myocardial revascularization surgery since 1945 A.D.

, 1976
Donald B. Effler
openalex   +1 more source

Fragility Index analysis for robustness of evidence in Randomized Controlled Trials in National Comprehensive Cancer Network (NCCN) guidelines for rectal cancer

International Journal of Cancer, EarlyView.
What's New? Data from randomized controlled trials (RCTs) forms a foundation for rectal cancer treatment guidelines. The reliability of such data is therefore essential for evidence‐based clinical decision‐making. This study assessed the robustness of RCTs cited in the latest National Comprehensive Cancer Network (NCCN) guidelines for rectal cancer ...
Nir Horesh, Justin Dourado, Peter Rogers, Pauline Aeschbacher, Zoe Garoufalia, Rachel Gefen, Ebram Salama, Sameh Hany Emile, Steven D. Wexner   +8 more
wiley   +1 more source

On-pump beating heart versus off-pump myocardial revascularization-a propensity-matched comparison. [PDF]

Indian J Thorac Cardiovasc Surg, 2021
Rao YM, Potdar S, Das D, Saha A, Kapoor L, Das M, Narayan P.   +6 more
europepmc   +1 more source

Complete Revascularization with Multivessel PCI for Myocardial Infarction.

New England Journal of Medicine, 2020
J. Auer, R. Berent, F. Gurtner
semanticscholar   +1 more source

Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects

The Journal of Clinical Pharmacology, EarlyView.
Abstract Recognition of benefits and adverse effects of therapies in earlier clinical trial phases could improve the safety, efficiency, and cost of clinical trials. Using four clinical trials representing a diverse set of diseases and drug classes (EXSCEL: exenatide/GLP‐1 RA, SUGAR‐DM‐HF: empagliflozin/SGLT2i, PRADA: epirubicin/anthracycline, and ...
Jessica Chadwick, Colin Berry, Meredith A. Carpenter, Geeta Gulati, Siri Lagethon Heck, Michael A. Hinterberg, Rury R. Holman, Matthew M.Y. Lee, Torbjørn Omland, Clare Paterson, Mark C. Petrie, Naveed Sattar, Svati H. Shah, Sama Shrestha, Harald Sourij, Emma V Troth, Victoria Vinje, Stephen A. Williams   +17 more
wiley   +1 more source

A Retrospective Study of the Relationship Between the Triglyceride Glucose Index and Myocardial Revascularization for New-Onset Acute Coronary Syndromes. [PDF]

Front Cardiovasc Med, 2022
Li J, Lin Y, Li H, Fan R, Lin L, Wang X, Jiang Y, Xia YL, Zhang B, Yang X.   +9 more
europepmc   +1 more source

Noncardioplegic myocardial preservation for coronary revascularization

, 1984
Cary W. Akins
openalex   +1 more source

Effect of P2Y12 Inhibitors on Major Adverse Cardiovascular Events After Coronary Artery Bypass Graft Surgery: A Population‐Based Cohort Study

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, EarlyView.
ABSTRACT Background Patients who undergo coronary artery bypass graft (CABG) surgery remain at high risk for major adverse cardiovascular events (MACE) despite contemporary preventive pharmacotherapy. Although commonly used in practice, it is uncertain whether P2Y12 inhibitors reduce MACE in patients post‐CABG surgery.
Arden R. Barry, Hamed Helisaz, Abdollah Safari, Peter S. Loewen   +3 more
wiley   +1 more source

PTEN in the Context of Myocardial Revascularization: The Iceberg Tip? [PDF]

Arq Bras Cardiol, 2023
Garcia LR, Garzesi AM, Felicio ML, Zornoff LAM.   +3 more
europepmc   +1 more source